157 related articles for article (PubMed ID: 27387531)
21. Lamotrigine Reduces β-Site AβPP-Cleaving Enzyme 1 Protein Levels Through Induction of Autophagy.
Wu H; Lu MH; Wang W; Zhang MY; Zhu QQ; Xia YY; Xu RX; Yang Y; Chen LH; Ma QH
J Alzheimers Dis; 2015; 46(4):863-76. PubMed ID: 25854934
[TBL] [Abstract][Full Text] [Related]
22. beta-Secretase, APP and Abeta in Alzheimer's disease.
Vassar R
Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
[TBL] [Abstract][Full Text] [Related]
23. Magnesium modulates amyloid-beta protein precursor trafficking and processing.
Yu J; Sun M; Chen Z; Lu J; Liu Y; Zhou L; Xu X; Fan D; Chui D
J Alzheimers Dis; 2010; 20(4):1091-106. PubMed ID: 20413885
[TBL] [Abstract][Full Text] [Related]
24. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.
Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S
J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619
[TBL] [Abstract][Full Text] [Related]
25. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
[TBL] [Abstract][Full Text] [Related]
26. A synthetic peptide corresponding to a region of the human pericentriolar material 1 (PCM-1) protein binds β-amyloid (Aβ1-42 ) oligomers.
Chakravarthy B; Ménard M; Brown L; Hewitt M; Atkinson T; Whitfield J
J Neurochem; 2013 Aug; 126(3):415-24. PubMed ID: 23432034
[TBL] [Abstract][Full Text] [Related]
27. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
28. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
[TBL] [Abstract][Full Text] [Related]
29. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
[TBL] [Abstract][Full Text] [Related]
30. ATBF1 is a novel amyloid-β protein precursor (AβPP) binding protein that affects AβPP expression.
Uhm KO; Kim MJ; Kawaguchi M; Akatsu H; Miura Y; Misumi S; Hida H; Choi EK; Kim YS; Michikawa M; Jung CG
J Alzheimers Dis; 2015; 43(1):243-57. PubMed ID: 25079792
[TBL] [Abstract][Full Text] [Related]
31. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
[TBL] [Abstract][Full Text] [Related]
32. Converging pathways of chromogranin and amyloid metabolism in the brain.
Mattsson N; Johansson P; Hansson O; Wallin A; Johansson JO; Andreasson U; Andersen O; Haghighi S; Olsson M; Stridsberg M; Svensson J; Blennow K; Zetterberg H
J Alzheimers Dis; 2010; 20(4):1039-49. PubMed ID: 20413871
[TBL] [Abstract][Full Text] [Related]
33. A Novel
Elovsson G; Klingstedt T; Brown M; Nilsson KPR; Brorsson AC
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396782
[TBL] [Abstract][Full Text] [Related]
34. Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study.
Welt T; Kulic L; Hoey SE; McAfoose J; Späni C; Chadha AS; Fisher A; Nitsch RM
J Alzheimers Dis; 2015; 46(4):971-82. PubMed ID: 25881909
[TBL] [Abstract][Full Text] [Related]
35. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
36. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
[TBL] [Abstract][Full Text] [Related]
37. The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease.
Pannee J; Törnqvist U; Westerlund A; Ingelsson M; Lannfelt L; Brinkmalm G; Persson R; Gobom J; Svensson J; Johansson P; Zetterberg H; Blennow K; Portelius E
Neurosci Lett; 2014 Jun; 573():7-12. PubMed ID: 24796810
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
39. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
[TBL] [Abstract][Full Text] [Related]
40. A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis.
Teng L; Zhao J; Wang F; Ma L; Pei G
Cell Res; 2010 Feb; 20(2):138-53. PubMed ID: 20066010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]